1. Tai Ji Quan as antihypertensive lifestyle therapy: A systematic review and meta-analysis
- Author
-
Yin Wu, Yiyang Chen, Blair T. Johnson, Linda S. Pescatello, Jill Livingston, and Shiqi Chen
- Subjects
Male ,medicine.medical_specialty ,Systole ,Diastole ,Blood Pressure ,Physical Therapy, Sports Therapy and Rehabilitation ,Review ,Prehypertension ,Exercise training ,lcsh:GV557-1198.995 ,03 medical and health sciences ,0302 clinical medicine ,Bias ,Internal medicine ,medicine ,Humans ,Aerobic exercise ,Orthopedics and Sports Medicine ,030212 general & internal medicine ,Lifestyle Therapy ,lcsh:Sports medicine ,Life Style ,lcsh:Sports ,business.industry ,Incidence (epidemiology) ,030229 sport sciences ,Middle Aged ,Blood pressure ,Meta-analysis ,Hypertension ,Female ,Tai Ji ,Methodological study ,lcsh:RC1200-1245 ,business ,Complementary medicine - Abstract
Highlights • First study that directly compared Tai Ji Quan trials published in English and Chinese with meta-regression analysis in the largest sample to date • In trials published in English, Tai Ji Quan reduces systolic blood pressure by 10 mm Hg and diastolic blood pressure 4 mm Hg among adults with hypertension • In trials published in Chinese, Tai Ji Quan reduces systolic pressure by 19 mm Hg and diastolic pressure by 9 mm Hg among adults with hypertension • More confidence should be placed in Tai Ji Quan trials published in English due to their higher methodological quality compared to trials published in Chinese, Background Professional health organizations are not currently recommending Tai Ji Quan alongside aerobic exercise to treat hypertension. We aimed to examine the efficacy of Tai Ji Quan as antihypertensive lifestyle therapy. Methods Tai Ji Quan interventions published in English and Chinese were included when they involved healthy adults, reported pre- and post-intervention blood pressure (BP), and had a non-exercise/non-diet control group. We systematically searched 11 electronic databases for studies published through July 31, 2018, yielding 31 qualifying controlled trials. We (1) evaluated the risk of bias and methodological study quality, (2) performed meta-regression analyses following random-effects assumptions, and (3) generated additive models representing the largest possible clinically relevant BP reductions. Results Participants (n = 3223) were middle-aged (56.6 ± 15.1 years of age, mean ± SD) adults with prehypertension (systolic BP (SBP) = 136.9 ± 15.2 mmHg, diastolic BP (DBP) = 83.4 ± 8.7 mmHg). Tai Ji Quan was practiced 4.0 ± 1.4 sessions/week for 54.0 ± 10.6 min/session for 22.3 ± 20.2 weeks. Overall, Tai Ji Quan elicited significant reductions in SBP (–11.3 mmHg, 95%CI: –14.6 to –8.0; d+ = –0.75) and DBP (–4.8 mmHg, 95%CI: –6.4 to –3.1; d+ = –0.53) vs. control (p < 0.001). Controlling for publication bias among samples with hypertension, Tai Ji Quan trials published in English elicited SBP reductions of 10.4 mmHg and DBP reductions of 4.0 mmHg, which was half the magnitude of trials published in Chinese (SBP reductions of 18.6 mmHg and DBP reductions of 8.8 mmHg). Conclusion Our results indicate that Tai Ji Quan is a viable antihypertensive lifestyle therapy that produces clinically meaningful BP reductions (i.e., 10.4 mmHg and 4.0 mmHg of SBP and DBP reductions, respectively) among individuals with hypertension. Such magnitude of BP reductions can lower the incidence of cardiovascular disease by up to 40%., Graphical Abstract Image, graphical abstract
- Published
- 2021
- Full Text
- View/download PDF